Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events

http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=1826818&contenttype=sentryarticle&channelID=26

Comments are closed.